ORMP vs. FMST

Last updated Apr 1, 2026

Compare and contrast key facts about Oramed Pharmaceuticals Inc. (ORMP) and Foremost Lithium Resource & Technology Ltd. Common stock (FMST).

Performance

ORMP vs. FMST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oramed Pharmaceuticals Inc. (ORMP) and Foremost Lithium Resource & Technology Ltd. Common stock (FMST). The values are adjusted to include any dividend payments, if applicable.

ORMP vs. FMST - Yearly Performance Comparison

	2026 (YTD)	2025
ORMP Oramed Pharmaceuticals Inc.	27.97%	27.23%
FMST Foremost Lithium Resource & Technology Ltd. Common stock	-16.98%	60.61%

Fundamentals

EPS ORMP : $1.03 FMST : -$0.27
Total Revenue (TTM) ORMP : $2.00M FMST : $0.00
Gross Profit (TTM) ORMP : -$79.00K FMST : $0.00
EBITDA (TTM) ORMP : $58.42M FMST : -$3.43M

Returns By Period

In the year-to-date period, ORMP achieves a 27.97% return, which is significantly higher than FMST's -16.98% return.

ORMP

• 1D: 3.66%
• 1M: -0.44%
• YTD: 27.97%
• 6M: 38.15%
• 1Y: 70.42%
• 3Y*: 18.71%
• 5Y*: -18.59%
• 10Y*: -6.63%

FMST

• 1D: 6.02%
• 1M: -22.47%
• YTD: -16.98%
• 6M: -39.73%
• 1Y: 117.28%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ORMP vs. FMST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORMP

ORMP Risk / Return Rank: 83
ORMP Sharpe Ratio Rank: 84
ORMP Sortino Ratio Rank: 83
ORMP Omega Ratio Rank: 77
ORMP Calmar Ratio Rank: 88
ORMP Martin Ratio Rank: 84

FMST

FMST Risk / Return Rank: 72
FMST Sharpe Ratio Rank: 72
FMST Sortino Ratio Rank: 81
FMST Omega Ratio Rank: 73
FMST Calmar Ratio Rank: 72
FMST Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORMP vs. FMST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oramed Pharmaceuticals Inc. (ORMP) and Foremost Lithium Resource & Technology Ltd. Common stock (FMST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ORMP	FMST	Difference
Sharpe ratio Return per unit of total volatility	1.45	0.92	+0.54
Sortino ratio Return per unit of downside risk	2.28	2.18	+0.10
Omega ratio Gain probability vs. loss probability	1.26	1.23	+0.03
Calmar ratio Return relative to maximum drawdown	3.44	1.54	+1.90
Martin ratio Return relative to average drawdown	7.67	2.34	+5.33
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ORMP vs. FMST - Sharpe Ratio Comparison

The current ORMP Sharpe Ratio is 1.45, which is higher than the FMST Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of ORMP and FMST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ORMP	FMST	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.45	0.92	+0.54
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.23	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.06	0.22	-0.29

Correlation

The correlation between ORMP and FMST is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ORMP vs. FMST - Dividend Comparison

ORMP's dividend yield for the trailing twelve months is around 7.35%, while FMST has not paid dividends to shareholders.

	TTM
ORMP Oramed Pharmaceuticals Inc.	7.35%
FMST Foremost Lithium Resource & Technology Ltd. Common stock	0.00%

Drawdowns

ORMP vs. FMST - Drawdown Comparison

The maximum ORMP drawdown since its inception was -94.25%, which is greater than FMST's maximum drawdown of -69.37%. Use the drawdown chart below to compare losses from any high point for ORMP and FMST.

Drawdown Indicators

	ORMP	FMST	Difference
Max Drawdown Largest peak-to-trough decline	-94.25%	-69.37%	-24.88%
Max Drawdown (1Y) Largest decline over 1 year	-18.89%	-69.37%	+50.48%
Max Drawdown (5Y) Largest decline over 5 years	-94.25%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-94.25%	—	—
Current Drawdown Current decline from peak	-87.74%	-67.53%	-20.21%
Average Drawdown Average peak-to-trough decline	-70.62%	-43.34%	-27.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.48%	45.75%	-37.27%

Volatility

ORMP vs. FMST - Volatility Comparison

The current volatility for Oramed Pharmaceuticals Inc. (ORMP) is 14.54%, while Foremost Lithium Resource & Technology Ltd. Common stock (FMST) has a volatility of 24.05%. This indicates that ORMP experiences smaller price fluctuations and is considered to be less risky than FMST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ORMP	FMST	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.54%	24.05%	-9.51%
Volatility (6M) Calculated over the trailing 6-month period	37.14%	70.49%	-33.35%
Volatility (1Y) Calculated over the trailing 1-year period	48.81%	128.52%	-79.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.19%	126.96%	-45.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.78%	126.96%	-54.18%

Financials